— Know what they know.
Not Investment Advice
Also trades as: KLBF.JK (JKT) · $vol 3M

PTKFF OTC

PT Kalbe Farma Tbk.
1W: +0.0% 1M: +0.0% 3M: +30.0% YTD: -27.0% 1Y: -16.3% 3Y: -52.1% 5Y: -40.8%
$0.05
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 54 · $2.4B mcap · 17.49B float · 0.0000% daily turnover · Short 79% of daily vol

📊 Key Metrics

TTM
$37,770B
Revenue
+13.2% YoY
$3,615B
Net Income
+6.0% YoY
$2,457B
Free Cash Flow
-16.0% YoY
35.9%
Gross Margin
11.8%
Op. Margin
9.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE15.4%
ROA11.5%
ROIC17.6%

Valuation

P/E9.1
P/B1.3
EV/EBITDA0.0

Leverage

Debt/Equity0.03
Current Ratio3.15
Interest Cov.122.4x

Quality Scores

Piotroski F5/9
Altman Z—
Beneish M-2.20

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms